# CARMENA (NCT00930033)

> Clinical Trial to Assess the Importance of Nephrectomy

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00930033
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: Assistance Publique - Hôpitaux de Paris
- Conditions: Metastatic Renal Cell Carcinoma
- Interventions: Nephrectomy; Sunitinib alone
- Enrollment: 452
- Primary outcome: The primary endpoint is overall survival.

## Commentary we found

- X threads: 33
- Podcasts: 6
- YouTube: 5

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=carmena-nct00930033

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00930033", "email": "<work email>"}; the inbox owner confirms by the emailed link.